NEW YORK (GenomeWeb News) – Bioinformatics firm Genome Compiler has raised $500,000 toward a targeted round of $5 million, the company said in a document filed with the US Securities and Exchange Commission this week.

The Northern California-based firm did not identify investors in the round or say how the proceeds will be used. In its Form D filed with the SEC, it said that the type of securities offered comprised equity and security to be acquired upon exercise of option, warrant, or other right to acquire security.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.

May
28
Sponsored by
PerkinElmer

This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.